glycine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Complexin II is reduced in Huntington's disease (HD) patients and in the R6/2 mouse model of HD." | 1.33 | A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouse. ( Brose, N; Gibson, HE; Jones, S; Morton, AJ; Reim, K, 2005) |
| "Mean glycine concentration was significantly increased (P < or = 0." | 1.30 | Huntington's disease: N-methyl-D-aspartate receptor coagonist glycine is increased in platelets. ( Lange, HW; Reilmann, R; Rolf, LH, 1997) |
| "Huntington's disease is a dominantly inherited, progressive neurodegenerative disorder causing marked pathology in the basal ganglia." | 1.28 | Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease. ( Dure, LS; Penney, JB; Young, AB, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| McGarry, A | 1 |
| Gaughan, J | 1 |
| Hackmyer, C | 1 |
| Lovett, J | 1 |
| Khadeer, M | 1 |
| Shaikh, H | 1 |
| Pradhan, B | 1 |
| Ferraro, TN | 1 |
| Wainer, IW | 1 |
| Moaddel, R | 1 |
| Wang, JQ | 1 |
| Chen, Q | 2 |
| Wang, X | 1 |
| Wang, QC | 1 |
| Wang, Y | 1 |
| Cheng, HP | 1 |
| Guo, C | 1 |
| Sun, Q | 1 |
| Tang, TS | 1 |
| Squitieri, F | 1 |
| Cannella, M | 1 |
| Simonelli, M | 1 |
| Rite, I | 1 |
| Machado, A | 1 |
| Cano, J | 1 |
| Venero, JL | 1 |
| Gibson, HE | 1 |
| Reim, K | 1 |
| Brose, N | 1 |
| Morton, AJ | 1 |
| Jones, S | 1 |
| Reynolds, GP | 1 |
| Pearson, SJ | 1 |
| Hutson, PH | 1 |
| Reilmann, R | 1 |
| Rolf, LH | 1 |
| Lange, HW | 1 |
| Calabresi, P | 1 |
| Centonze, D | 1 |
| Pisani, A | 1 |
| Bernardi, G | 1 |
| Tourian, A | 1 |
| Hung, W | 1 |
| Dure, LS | 1 |
| Young, AB | 1 |
| Penney, JB | 1 |
| Vamvakides, A | 1 |
| Bonilla, E | 1 |
| Prasad, AL | 1 |
| Arrieta, A | 1 |
| Simanyi, M | 1 |
| Gerstenbrand, F | 1 |
| Gründig, E | 1 |
| Schedl, R | 1 |
| Weiss, H | 1 |
1 review available for glycine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
[A hypothesis for pharmacologic research on GABAergic approaches in Huntington chorea].
Topics: Animals; Central Nervous System; gamma-Aminobutyric Acid; Glutamates; Glycine; Humans; Huntington Di | 1989 |
12 other studies available for glycine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot study.
Topics: Adult; Arginine; Biomarkers; Creatine; Cross-Sectional Studies; Disability Evaluation; Female; Glyci | 2020 |
Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease.
Topics: Animals; Bradykinin; Calcium; Calcium Channels; Calcium Signaling; DNA Damage; DNA, Mitochondrial; E | 2013 |
CAG mutation effect on rate of progression in Huntington's disease.
Topics: Age of Onset; Alanine; Cysteine; Disease Progression; DNA Mutational Analysis; Female; Follow-Up Stu | 2002 |
Divergent regulatory mechanisms governing BDNF mRNA expression in cerebral cortex and substantia nigra in response to striatal target ablation.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Corpus Striatum; Cyclopropanes; Denerva | 2005 |
A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouse.
Topics: 2-Amino-5-phosphonovalerate; Adaptor Proteins, Vesicular Transport; Age Factors; Animals; Anticonvul | 2005 |
Deficit of [3H]L-689,560 binding to the glycine site of the glutamate/NMDA receptor in the brain in Huntington's disease.
Topics: Adult; Aged; Aminoquinolines; Binding Sites; Cadaver; Caudate Nucleus; Female; Frontal Lobe; Glycine | 1994 |
Huntington's disease: N-methyl-D-aspartate receptor coagonist glycine is increased in platelets.
Topics: Adult; Blood Platelets; Female; Glycine; Humans; Huntington Disease; Male; Middle Aged; Models, Neur | 1997 |
Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease.
Topics: Animals; Brain Ischemia; Calcium Channels; Cell Communication; Cells, Cultured; Cerebral Cortex; Cho | 1999 |
Glucosamine dependence of Huntington's chorea fibroblasts in culture.
Topics: Asparagine; Fibroblasts; Glucosamine; Glutamine; Glycine; Huntington Disease | 1976 |
Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.
Topics: Adolescent; Adult; Age Factors; Aged; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Bind | 1991 |
Huntington's disease: studies on brain free amino acids.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Aspartic Acid; Brain; Female; gamma-Aminobutyric Acid; | 1988 |
[Effect of administration of amino acids, especially of L-DOPA and -methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. 3. Alterations of cerebrospinal fluid in patients with Huntington's chorea after -methyldopa or L-DOPA
Topics: Adult; Aged; Alanine Transaminase; Asparagine; Aspartic Acid; Child; Dihydroxyphenylalanine; Female; | 1973 |